Article
Oncology
Il Hwan Oh, Jung-Soo Pyo, Byoung Kwan Son
Summary: This study found that YKL-40 expression in CRC tissues is associated with tumor differentiation and PD-L1 expression. The expression of I-YKL-40 can be useful for prognostic risk stratification in CRC patients.
Article
Multidisciplinary Sciences
Kristina Jansen, Franziska Buescheck, Katharina Moeller, Martina Kluth, Claudia Hube-Magg, Niclas Christian Blessin, Daniel Perez, Jakob Izbicki, Michael Neipp, Hamid Mofid, Thies Daniels, Ulf Nahrstede, Christoph Fraune, Frank Jacobsen, Christian Bernreuther, Patrick Lebok, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Ronald Simon, Stefan Steurer, Eike Burandt, Andreas Marx, Till Krech, Till Clauditz
Summary: DOG1 is commonly expressed in pancreatic cancer but absent in normal pancreas. It may serve as a potential biomarker for pancreatic cancer diagnosis, but is unrelated to cancer aggressiveness.
Article
Surgery
Eray Celikturk, Omer Salt, Mustafa Burak Sayhan, Ilker Dibirdik
Summary: This study aimed to measure plasma YKL-40 levels and investigate their diagnostic value in patients with acute cholecystitis. The results showed a significant difference in YKL-40 protein levels between patients with acute cholecystitis and healthy volunteers, and a positive correlation with ALT, AST, LDH, and GGT levels. Therefore, plasma YKL-40 levels can be effectively used in the diagnosis of acute cholecystitis when evaluated together with physical examination, radiological imaging, and other laboratory parameters.
ASIAN JOURNAL OF SURGERY
(2023)
Article
Immunology
Astrid Z. Johansen, Sif I. Novitski, Jessica X. Hjaltelin, Susann Theile, Mogens K. Boisen, Soren Brunak, Daniel H. Madsen, Dorte L. Nielsen, Inna M. Chen
Summary: In this study, the association between plasma YKL-40 levels and clinical benefit and survival in patients with metastatic pancreatic cancer (mPC) receiving immune checkpoint inhibitors (ICIs) and stereotactic body radiotherapy (SBRT) was investigated. The results showed that elevated baseline plasma YKL-40 levels were associated with shorter overall survival, while a greater than 40% decrease in plasma YKL-40 levels during treatment was associated with longer progression-free survival and overall survival. These findings suggest that YKL-40 may serve as a potential biomarker for patients treated with immunotherapies.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Pathology
Viktor Reiswich, Steffi Koenemann, Maximilian Lennartz, Doris Hoeflmayer, Anne Menz, Viktoria Chirico, Claudia Hube-Magg, Christoph Fraune, Christian Bernreuther, Ronald Simon, Till S. Clauditz, Guido Sauter, Andrea Hinsch, Simon Kind, Frank Jacobsen, Stefan Steurer, Sarah Minner, Franziska Buescheck, Eike Burandt, Andreas H. Marx, Patrick Lebok, Till Krech
Summary: Uroplakin 1A (Upk1a) protein plays a role in stabilizing and strengthening urothelial cells, but its expression varies in different types of tumors. Upk1a immunohistochemistry is a potentially useful diagnostic marker, but its sensitivity is low in invasive tumors.
PATHOLOGY RESEARCH AND PRACTICE
(2022)
Article
Medicine, General & Internal
Hailong Hao, Huiqing Chen, Liwu Xie, Hongyu Liu
Summary: The study aimed to investigate the relationship between YKL-40 and recurrence and progression of bladder cancer, and to determine its potential as a therapeutic target. Results showed that YKL-40 promoted migration and invasion of bladder cancer cells, with its expression closely linked to the invasiveness and metastasis of bladder cancer.
ANNALS OF MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Soren Weidemann, Pauline Gagelmann, Natalia Gorbokon, Maximilian Lennartz, Anne Menz, Andreas M. Luebke, Martina Kluth, Claudia Hube-Magg, Niclas C. Blessin, Christoph Fraune, Katharina Moller, Christian Bernreuther, Patrick Lebok, Till S. Clauditz, Frank Jacobsen, Jakob R. Izbicki, Kristina Jansen, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Sarah Minner, Eike Burandt, Rainer H. Krech, David Dum, Till Krech, Andreas H. Marx, Ronald Simon
Summary: Analysis of MSLN expression in 15,050 tumors identified numerous important cancer types with high-level expression, indicating potential benefits from future anti-MSLN therapies. However, the prognostic relevance of MSLN appears to be limited.
Article
Biochemistry & Molecular Biology
Maria Gevezova, Maria Kazakova, Anastasia Trenova, Victoria Sarafian
Summary: Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. There is growing evidence suggesting that mitochondrial dysfunction and inflammation play a crucial role in the pathogenesis of PD. This study investigated the metabolic profile of peripheral blood mononuclear cells (PBMCs) from PD patients and found changes in mitochondrial activity and YKL-40 levels in PD patients. The protein levels of YKL-40 were threefold higher in PD and showed a correlation with basal respiration and ATP production. These findings suggest an interplay between YKL-40 and mitochondrial function in PD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Cell Biology
Kristina Jansen, Martina Kluth, Niclas C. Blessin, Claudia Hube-Magg, Michael Neipp, Hamid Mofid, Hannes Larusson, Thies Daniels, Christoph Isbert, Stephan Coerper, Daniel Ditterich, Holger Rupprecht, Albert Goetz, Christian Bernreuther, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Ronald Simon, Stefan Steurer, Eike Burandt, Daniel Perez, Jakob R. Izbicki, Frank Jacobsen, Till S. Clauditz, Andreas H. Marx, Till Krech
Summary: Elevated DOG1 expression is associated with important molecular alterations in colorectal cancer, but unrelated to histopathological parameters of tumor aggressiveness.
HISTOLOGY AND HISTOPATHOLOGY
(2022)
Article
Pathology
David Dum, Anne Menz, Cosima Voekel, Noemi De Wispelaere, Andrea Hinsch, Natalia Gorbokon, Maximilian Lennartz, Andreas M. Luebke, Claudia Hube-Magg, Martina Kluth, Christoph Fraune, Christian Bernreuther, Patrick Lebok, Till S. Clauditz, Frank Jacobsen, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Katharina Moller, Stefan Steurer, Sarah Minner, Andreas H. Marx, Ronald Simon, Eike Burandt, Till Krech
Summary: The combined analysis of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) is often used to assess the origin of metastatic cancer. This study analyzed tissue microarrays containing 15,424 tumor samples and 608 normal tissue samples using immunohistochemistry. The results showed that CK7 was positive in 52% of tumors, while CK20 was positive in 23% of tumors. The combined evaluation of CK7 and CK20 demonstrated the best diagnostic utility in CK20 positive tumors.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
(2022)
Review
Medicine, General & Internal
Krzysztof Specjalski, Jan Romantowski, Marek Niedoszytko
Summary: Asthma is a chronic disorder characterized by inflammation and bronchial hyperresponsiveness. Chitinases and chitinase-like proteins (CLPs) have been suggested as potential biomarkers for diagnosing asthma and phenotyping the disease. However, the low specificity of these biomarkers limits their practical application.
FRONTIERS IN MEDICINE
(2023)
Article
Clinical Neurology
Wiesje Pelkmans, Mahnaz Shekari, Anna Brugulat-Serrat, Gonzalo Sanchez-Benavides, Carolina Minguillon, Karine Fauria, Jose Luis Molinuevo, Oriol Grau-Rivera, Armand Gonzalez Escalante, Gwendlyn Kollmorgen, Margherita Carboni, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Marc Suarez-Calvet, Juan Domingo Gispert
Summary: We studied the role of biomarkers of reactive astrogliosis in the pathogenic cascade of Alzheimer's disease. Various fluid biomarkers were found to influence the progression of the disease, with GFAP mediating the association between soluble and insoluble Aβ, and YKL-40 partly explaining the association between Aβ and downstream tau pathology and neuronal injury.
ALZHEIMERS & DEMENTIA
(2023)
Article
Oncology
Ziyi Wang, Shijia Wang, Ziheng Jia, Yunping Hu, Dongyan Cao, Mingjie Yang, Liguo Liu, Li Gao, Shimei Qiu, Weikang Yan, Yiming Li, Jing Luo, Yajun Geng, Jingyun Zhang, Zhizhen Li, Xuan Wang, Maolan Li, Rong Shao, Yingbin Liu
Summary: Little is known about the molecular regulation of the tumor immunosuppressive microenvironment in gallbladder cancer (GBC) with high lethality. This study found that elevated expression levels of YKL-40 in plasma and tissue were associated with tumor size, stage IV, and lymph node metastasis in GBC. YKL-40 was predominantly derived from M2-like subtype of infiltrating macrophages and played a role in promoting PD-L1 expression and inhibition of T cell cytotoxicity through the induction of growth differentiation factor 15 (GDF15). These findings suggest that YKL-40 and GDF15 could be potential diagnostic biomarkers and immunotherapeutic targets for GBC.
Article
Dermatology
Yomna Mazid El-Hamd Neinaa, Hadeer Tarek Ismaiel Elsayed, Hanan Alsaeid Alshenawy, Mohamed Mahmoud Gamei
Summary: This study investigated the immune expression of YKL-40 in different stages of mycosis fungoides (MF) and found that the expression of YKL-40 was significantly increased in MF lesions. Positive correlations were found between YKL-40 expression and patients' age, disease chronicity, clinical staging, and TNMB classification. The study concluded that YKL-40 may participate in MF pathophysiology and its high expression is associated with advanced stages of the disease and poor outcomes. Therefore, it may serve as a valuable prognosticator for monitoring high-risk MF patients and assessing treatment success.
INTERNATIONAL JOURNAL OF DERMATOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Kalthoum Tizaoui, Jae Won Yang, Keum Hwa Lee, Ji Hong Kim, Minseok Kim, Sojung Yoon, Yeonwoo Jung, Joon Beom Park, Kitae An, Hyeok Choi, Donggyu Song, HyunTaek Jung, Seongmin Ahn, Taeho Yuh, Hee Min Choi, Jae Ha Ahn, Younjuong Kim, Sanghyun Jee, Hyeongsun Lee, Soohwa Jun, Jun-Gu Kang, Bohyun Koo, Joo Yeop Lee, Kyoung Min Min, Wonseok Yoo, Hyeong Jun Rhyu, Yeonjung Yoon, Min Ho Lee, Sung Eun Kim, Jimin Hwang, Ai Koyanagi, Louis Jacob, Seoyeon Park, Jae Il Shin, Lee Smith
Summary: YKL-40, also known as CHI3L1 or HC gp-39, is a protein expressed by various cell types and speculated to be related to inflammatory reactions and autoimmune diseases. Studies have shown its potential as a marker for disease diagnosis, prognosis, disease activity, and treatment response, particularly in rheumatoid arthritis and psoriasis, but further research is needed to elucidate its exact role in autoimmunity.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2022)